ACE2 and COVID-19: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is initiated after type 2 transmembrane protease (TMPRSS2) cleaves the viral spike glycoprotein, which then binds to the angiotensin-converting enzyme 2 (ACE-2) receptor.